Prescription Information Modernization Act of 2023

HR 1503, the Prescription Information Modernization Act of 2023, allows drug manufacturers to provide FDA-approved prescribing information exclusively via digital means (like email or online portals) to doctors and pharmacists, while requiring them to still offer paper copies upon request at no extra cost. The bill directly affects drug manufacturers and distributors, who must implement this change by 2025 (or when regulations take effect), and ensures prescribers and dispensers can choose their preferred format. Key provisions include mandating manufacturers to honor paper requests promptly without additional fees and requiring the Health Secretary to issue implementing regulations within one year. The law aims to modernize how medical information is shared while maintaining accessibility for healthcare providers.